NYSE:NGVT Ingevity (NGVT) Stock Forecast, Price & News $51.81 +4.36 (+9.19%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$48.35▼$51.8750-Day Range$47.19▼$74.0152-Week Range$46.52▼$90.81Volume435,807 shsAverage Volume408,641 shsMarket Capitalization$1.88 billionP/E Ratio9.81Dividend YieldN/APrice Target$66.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Ingevity MarketRank™ ForecastAnalyst RatingHold2.33 Rating ScoreUpside/Downside28.0% Upside$66.33 Price TargetShort InterestHealthy1.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.80Based on 3 Articles This WeekInsider TradingSelling Shares$116,559 Sold Last QuarterProj. Earnings Growth23.64%From $5.50 to $6.80 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.88 out of 5 starsBasic Materials Sector22nd out of 163 stocksChemicals & Allied Products Industry4th out of 16 stocks 3.2 Analyst's Opinion Consensus RatingIngevity has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $66.33, Ingevity has a forecasted upside of 28.0% from its current price of $51.81.Amount of Analyst CoverageIngevity has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.87% of the float of Ingevity has been sold short.Short Interest Ratio / Days to CoverIngevity has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ingevity has recently decreased by 20.85%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldIngevity does not currently pay a dividend.Dividend GrowthIngevity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NGVT. Previous Next 2.7 News and Social Media Coverage News SentimentIngevity has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Ingevity this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for NGVT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added Ingevity to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ingevity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $116,559.00 in company stock.Percentage Held by InsidersOnly 0.79% of the stock of Ingevity is held by insiders.Percentage Held by Institutions90.01% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Ingevity are expected to grow by 23.64% in the coming year, from $5.50 to $6.80 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ingevity is 9.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.14.Price to Earnings Ratio vs. SectorThe P/E ratio of Ingevity is 9.81, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 96.45.Price to Book Value per Share RatioIngevity has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Ingevity (NYSE:NGVT) StockIngevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.Read More Receive NGVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter. Email Address NGVT Stock News HeadlinesMay 27, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) Hits New 12-Month Low at $49.29May 25, 2023 | stockhouse.comIngevity makes splash with fresh water environment biodegradability certification for Capa® thermoplastic technologyJune 4, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 23, 2023 | markets.businessinsider.comWhat 7 Analyst Ratings Have To Say About IngevityMay 23, 2023 | markets.businessinsider.comBMO Capital Remains a Buy on Ingevity (NGVT)May 23, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) PT Lowered to $55.00May 18, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) Receives New Coverage from Analysts at StockNews.comMay 12, 2023 | barrons.comIngevity Capa(R) thermoplastic technology earns Biodegradable Products Institute compostable certificationJune 4, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 12, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) PT Lowered to $80.00 at BMO Capital MarketsMay 11, 2023 | finance.yahoo.comIngevity Capa® thermoplastic technology earns Biodegradable Products Institute compostable certificationMay 8, 2023 | finance.yahoo.comIngevity's (NGVT) Earnings and Revenues Lag Estimates in Q1May 6, 2023 | seekingalpha.comIngevity Corporation 2023 Q1 - Results - Earnings Call PresentationMay 6, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) Downgraded to "Hold" at Loop CapitalMay 3, 2023 | finance.yahoo.comIngevity (NGVT) Q1 Earnings and Revenues Miss EstimatesApril 29, 2023 | finance.yahoo.comAt US$71.74, Is It Time To Put Ingevity Corporation (NYSE:NGVT) On Your Watch List?April 26, 2023 | americanbankingnews.comIngevity (NGVT) to Release Earnings on WednesdayApril 20, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) Price Target Lowered to $80.00 at Wells Fargo & CompanyApril 17, 2023 | msn.comWells Fargo Maintains Ingevity (NGVT) Equal-Weight RecommendationMarch 29, 2023 | finance.yahoo.comIngevity (NGVT) Down 16.8% Since Last Earnings Report: Can It Rebound?March 25, 2023 | americanbankingnews.comIngevity (NYSE:NGVT) Given New $92.00 Price Target at Loop CapitalMarch 23, 2023 | americanbankingnews.comFinancial Survey: Standard Lithium (OTCMKTS:SLI) versus Ingevity (NYSE:NGVT)March 15, 2023 | finance.yahoo.comIngevity (NGVT) to Feature Capa at European Coatings ShowMarch 13, 2023 | finance.yahoo.comIngevity Corporation (NYSE:NGVT) Q4 2022 Earnings Call TranscriptFebruary 28, 2023 | finance.yahoo.comIngevity (NGVT) Lags Q4 Earnings and Revenue EstimatesFebruary 21, 2023 | finance.yahoo.comIngevity pushes boundaries of polyurethane performance with Capa® LT, a new Capa polyol with extended low temperature performanceFebruary 21, 2023 | msn.comChart of the Day: Ingevity - Special Chemical StockSee More Headlines NGVT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NGVT Company Calendar Last Earnings5/03/2023Today6/03/2023Next Earnings (Estimated)8/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CUSIPN/A CIK1653477 Webwww.ingevity.com Phone(843) 740-2300Fax843-740-8165Employees2,050Year FoundedN/APrice Target and Rating Average Stock Price Forecast$66.33 High Stock Price Forecast$80.00 Low Stock Price Forecast$55.00 Forecasted Upside/Downside+28.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$5.28 Trailing P/E Ratio9.81 Forward P/E Ratio9.42 P/E GrowthN/ANet Income$211.60 million Net Margins12.01% Pretax Margin15.26% Return on Equity30.82% Return on Assets8.19% Debt Debt-to-Equity Ratio2.07 Current Ratio2.57 Quick Ratio1.27 Sales & Book Value Annual Sales$1.68 billion Price / Sales1.12 Cash Flow$9.94 per share Price / Cash Flow5.21 Book Value$19.98 per share Price / Book2.59Miscellaneous Outstanding Shares36,331,000Free Float36,044,000Market Cap$1.88 billion OptionableOptionable Beta1.83 Key ExecutivesJohn C. FortsonPresident, Chief Executive Officer & DirectorMary Dean HallChief Financial Officer & Executive Vice PresidentStuart Edward WoodcockExecutive VP & President-Performance MaterialsErik RippleSenior VP, Chief Growth & Innovation OfficerSteven Paul HulmeSVP & President-Advanced Polymer TechnologiesKey CompetitorsInnospecNASDAQ:IOSPHawkinsNASDAQ:HWKNPerimeter SolutionsNYSE:PRMBalchemNASDAQ:BCPCChemoursNYSE:CCView All CompetitorsInsiders & InstitutionsMacquarie Group Ltd.Bought 10,665 shares on 6/1/2023Ownership: 0.030%Ontario Teachers Pension Plan BoardSold 34,032 shares on 6/1/2023Ownership: 0.014%ProShare Advisors LLCBought 442 shares on 5/26/2023Ownership: 0.020%Putnam Investments LLCBought 31,937 shares on 5/22/2023Ownership: 0.297%Ameriprise Financial Inc.Bought 1,465 shares on 5/22/2023Ownership: 0.217%View All Insider TransactionsView All Institutional Transactions NGVT Stock - Frequently Asked Questions Should I buy or sell Ingevity stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares. View NGVT analyst ratings or view top-rated stocks. What is Ingevity's stock price forecast for 2023? 3 brokers have issued 12-month price targets for Ingevity's stock. Their NGVT share price forecasts range from $55.00 to $80.00. On average, they anticipate the company's stock price to reach $66.33 in the next year. This suggests a possible upside of 28.0% from the stock's current price. View analysts price targets for NGVT or view top-rated stocks among Wall Street analysts. How have NGVT shares performed in 2023? Ingevity's stock was trading at $70.44 at the beginning of 2023. Since then, NGVT shares have decreased by 26.4% and is now trading at $51.81. View the best growth stocks for 2023 here. Are investors shorting Ingevity? Ingevity saw a drop in short interest in May. As of May 15th, there was short interest totaling 672,500 shares, a drop of 20.8% from the April 30th total of 849,600 shares. Based on an average daily trading volume, of 330,400 shares, the short-interest ratio is currently 2.0 days. Currently, 1.9% of the company's stock are sold short. View Ingevity's Short Interest. When is Ingevity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023. View our NGVT earnings forecast. How were Ingevity's earnings last quarter? Ingevity Co. (NYSE:NGVT) issued its quarterly earnings results on Wednesday, May, 3rd. The company reported $1.09 EPS for the quarter, missing analysts' consensus estimates of $1.26 by $0.17. The business earned $392.60 million during the quarter, compared to analyst estimates of $411.22 million. Ingevity had a net margin of 12.01% and a trailing twelve-month return on equity of 30.82%. The company's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.62 EPS. What ETFs hold Ingevity's stock? ETFs with the largest weight of Ingevity (NYSE:NGVT) stock in their portfolio include ProShares Smart Materials ETF (TINT), Putnam BioRevolution ETF (SYNB), Thrivent Small-Mid Cap ESG ETF (TSME), Putnam Sustainable Future ETF (PFUT), Pacer US Export Leaders ETF (PEXL), iShares U.S. Infrastructure ETF (IFRA), Invesco S&P MidCap Quality ETF (XMHQ) and First Trust Small Cap Value AlphaDEX Fund (FYT). What guidance has Ingevity issued on next quarter's earnings? Ingevity updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.75 billion-$1.95 billion, compared to the consensus revenue estimate of $1.92 billion. What is John Fortson's approval rating as Ingevity's CEO? 2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ). What is Ingevity's stock symbol? Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT." Who are Ingevity's major shareholders? Ingevity's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.05%), LSV Asset Management (4.08%), Wellington Management Group LLP (3.65%), State Street Corp (3.33%), Thrivent Financial for Lutherans (3.14%) and Victory Capital Management Inc. (2.38%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock. View institutional ownership trends. How do I buy shares of Ingevity? Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ingevity's stock price today? One share of NGVT stock can currently be purchased for approximately $51.81. How much money does Ingevity make? Ingevity (NYSE:NGVT) has a market capitalization of $1.88 billion and generates $1.68 billion in revenue each year. The company earns $211.60 million in net income (profit) each year or $5.28 on an earnings per share basis. How many employees does Ingevity have? The company employs 2,050 workers across the globe. How can I contact Ingevity? Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165. This page (NYSE:NGVT) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ingevity Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.